Search research articles
Contact Us
Filters
Showing results (161-170 of 168) with videos related to
Page
of 17
Sort By:
You have reached the last page of results.
This site can display upto 168 results.
Journal of Thrombosis and Haemostasis : JTH
|
January 9, 2021
Pharmacological targeting of coagulation factor XI mitigates the development of experimental atherosclerosis in low-density lipoprotein receptor-deficient mice
Anh T P Ngo, Kelley R Jordan, Paul A Mueller, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
November 16, 2023
Factor XI Inhibition for the Prevention of Catheter-Associated Thrombosis in Patients With Cancer Undergoing Central Line Placement: A Phase 2 Clinical Trial
Michael A Pfeffer, Tia C L Kohs, Helen H Vu, et al.
Research and Practice in Thrombosis and Haemostasis
|
January 16, 2024
Activation of coagulation FXI promotes endothelial inflammation and amplifies platelet activation in a nonhuman primate model of hyperlipidemia
Tia C L Kohs, Helen H Vu, Kelley R Jordan, et al.
Journal of Thrombosis and Haemostasis : JTH
|
June 29, 2025
Protective effects of factor XI inhibition by abelacimab in a baboon model of live Staphylococcus aureus sepsis
Robert Silasi, Ravi S Keshari, Tomohiro Abe, et al.
Blood
|
January 27, 2023
Factor XII contributes to thrombotic complications and vaso-occlusion in sickle cell disease
Erica M Sparkenbaugh, Michael W Henderson, Megan Miller-Awe, et al.
Research and Practice in Thrombosis and Haemostasis
|
July 21, 2020
Illustrated State-of-the-Art Capsules of the ISTH 2020 Congress
Robert Ariens, Cecilia Becattini, Markus Bender, et al.
Biorxiv : the Preprint Server for Biology
|
May 13, 2026
Bradykinin Contributes to Vasogenic Edema in Murine Experimental Cerebral Malaria
Alessandro de Sa Pinheiro, Douglas E Teixeira, Rodrigo P Silva-Aguiar, et al.
The Lancet. Neurology
|
December 15, 2023
Safety and efficacy of factor XIa inhibition with milvexian for secondary stroke prevention (AXIOMATIC-SSP): a phase 2, international, randomised, double-blind, placebo-controlled, dose-finding trial
Mukul Sharma, Carlos A Molina, Kazunori Toyoda, et al.
Page
of 17
Search research articles
Search
Showing results (161-170 of 168) with videos related to
Sort By:
Page
of 17
You have reached the last page of results.
This site can display upto 168 results.
Journal of Thrombosis and Haemostasis : JTH
|
January 9, 2021
Pharmacological targeting of coagulation factor XI mitigates the development of experimental atherosclerosis in low-density lipoprotein receptor-deficient mice
Anh T P Ngo, Kelley R Jordan, Paul A Mueller, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
November 16, 2023
Factor XI Inhibition for the Prevention of Catheter-Associated Thrombosis in Patients With Cancer Undergoing Central Line Placement: A Phase 2 Clinical Trial
Michael A Pfeffer, Tia C L Kohs, Helen H Vu, et al.
Research and Practice in Thrombosis and Haemostasis
|
January 16, 2024
Activation of coagulation FXI promotes endothelial inflammation and amplifies platelet activation in a nonhuman primate model of hyperlipidemia
Tia C L Kohs, Helen H Vu, Kelley R Jordan, et al.
Journal of Thrombosis and Haemostasis : JTH
|
June 29, 2025
Protective effects of factor XI inhibition by abelacimab in a baboon model of live Staphylococcus aureus sepsis
Robert Silasi, Ravi S Keshari, Tomohiro Abe, et al.
Blood
|
January 27, 2023
Factor XII contributes to thrombotic complications and vaso-occlusion in sickle cell disease
Erica M Sparkenbaugh, Michael W Henderson, Megan Miller-Awe, et al.
Research and Practice in Thrombosis and Haemostasis
|
July 21, 2020
Illustrated State-of-the-Art Capsules of the ISTH 2020 Congress
Robert Ariens, Cecilia Becattini, Markus Bender, et al.
Biorxiv : the Preprint Server for Biology
|
May 13, 2026
Bradykinin Contributes to Vasogenic Edema in Murine Experimental Cerebral Malaria
Alessandro de Sa Pinheiro, Douglas E Teixeira, Rodrigo P Silva-Aguiar, et al.
The Lancet. Neurology
|
December 15, 2023
Safety and efficacy of factor XIa inhibition with milvexian for secondary stroke prevention (AXIOMATIC-SSP): a phase 2, international, randomised, double-blind, placebo-controlled, dose-finding trial
Mukul Sharma, Carlos A Molina, Kazunori Toyoda, et al.
Page
of 17